Alzheimer's Patients Could Die From Risperdal: Study
A new study has found that Alzheimer's disease patients who take anti-psychotic drugs such as Johnson & Johnson's Risperdal may face a doubled risk of death, further bolstering concerns over a...To view the full article, register now.
Already a subscriber? Click here to view full article